[fusion_builder_container backgroundcolor="" backgroundimage="" backgroundrepeat="no-repeat" backgroundposition="left top" backgroundattachment="scroll" video_webm="" video_mp4="" video_ogv="" video_preview_image="" overlay_color="" overlay_opacity="0.5" video_mute="yes" video_loop="yes" fade="no" bordersize="0px" bordercolor="" borderstyle="" paddingtop="20px" paddingbottom="20px" paddingleft="0px" paddingright="0px" menu_anchor="" equal_height_columns="no" hundred_percent="no" class="" id=""][fusion_builder_row][fusion_builder_column type="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" spacing="yes" background_image="" background_repeat="no-repeat" padding="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="no" center_content="no" min_height="none"][fusion_text]The neuroAD system by Neuronix is an innovative, safe and effective non-pharmaceutical treatment alternative for mild to moderate Alzheimer’s Disease. It is the first medical device in the world cleared for this indication.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
[email protected] Tel. +39 06 92595490 Fax +39 06 89360010 Certified email [email protected]
Raffaella Broccardo | [email protected]
Marco Maria Fedeli | [email protected], [email protected]
Edoardo Menna | [email protected] Tel. +39 337 113 84 07
Rosaria Tremamunno | [email protected] Tel. +39 348 991 4487
Andrea Napolitano | [email protected] Tel. +39 329 4757978
Silvia Assogna | [email protected]
Carmine Pontecorvo | [email protected]
Carmine Pontecorvo | [email protected]
Fabrizio Pieralisi | [email protected], [email protected]